Please use this identifier to cite or link to this item:
|Title:||Size-dependent immunogenicity: therapeutic and protective properties of nano-vaccines against tumors.|
|Authors:||Fifis, Theodora;Gamvrellis, Anita;Crimeen-Irwin, Blessing;Pietersz, Geoffrey A;Li, Jie;Mottram, Patricia L;McKenzie, Ian F C;Plebanski, Magdalena|
|Affiliation:||Austin Research Institute, Austin Hospital, Heidelberg, Victoria, Australia.|
|Citation:||Journal of Immunology (baltimore, Md. : 1950); 173(5): 3148-54|
|Abstract:||Infection can protect against subsequent disease by induction of both humoral and cellular immunity, but inert protein-based vaccines are not as effective. In this study, we present a new vaccine design, with Ag covalently conjugated to solid core nano-beads of narrowly defined size (0.04-0.05 microm) that localize to dendritic cells (DEC205(+) CD40(+), CD86(+)) in draining lymph nodes, inducing high levels of IFN-gamma production (CD8 T cells: precursor frequencies 1/5000 to 1/1000) and high Ab titers in mice. Conjugation of Ag to these nano-beads induced responses that were significantly higher (2- to 10-fold) than those elicited by other bead sizes, and higher than a range of currently used adjuvants (alum, QuilA, monophosphoryl lipid A). Responses were comparable to CFA/IFA immunization for Abs and ex vivo peptide-pulsed dendritic cell immunization for CD8 T cells. A single dose of Ag-conjugated beads protected mice from tumors in two different model challenges and caused rapid clearance of established tumors in mice. Thus, a range of Ags conjugated to nano-beads was effective as immunogens in both therapeutic and prophylactic scenarios.|
|Internal ID Number:||15322175|
Disease Models, Animal
Neoplasms.drug therapy.immunology.prevention & control
|Appears in Collections:||Journal articles|
Files in This Item:
There are no files associated with this item.
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.